NP-G2-044 | Interleukin Related interleukin-related.com

Product Name :
NP-G2-044

Search keywords :
NP-G2-044

drugId :
null

Target Vo:
Fascin

Target Vo Short Name :
Fascin

Moa_Name:
Fascin inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Novita Pharmaceuticals Inc

Active Company_Name :
China Resources Double-Crane Pharmaceutical Co Ltd

Active Indication_Name:
Solid tumours

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
JAK2 Mouse mAb Formula
Smad3 Rabbit mAb Purity & Documentation
YAP1 Antibody: YAP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 54 kDa, targeting to YAP1. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts